Valuation GSK plc

Stocks

Market Closed - London S.E. Other stock markets 19:35:12 16/07/2026 +04			5-day change	1st Jan Change
1,956.00 ^GBX	+2.06%		-0.18%	+7.21%

07:54pm	India's Serum Institute partners with Gates MRI to make experimental TB vaccine	RE
07-15	GSK Completes $10.6 Billion Acquisition of Nuvalent	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,325	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.27%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	91,612	88,549	85,366
Change	-	-24.65%	-1.89%	-8.24%	28.83%	4.51%	-3.34%	-3.59%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12.1x	11.1x	11x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.42x	3.69x	3.18x
PEG	-	0x	-0.2x	-0.4x	0x	1x	1.21x	10.76x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.25x	2.14x	2.08x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.7x	2.49x	2.32x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.81x	7.04x	6.66x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	8.95x	7.99x	7.43x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.1x	14.5x	13.2x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.22%	6.89%	7.57%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6968	0.7336	0.7663
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.64%	3.83%	4%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.579	1.724	1.742
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	44.1%	42.5%	44%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,883	35,626	36,737
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,734	12,571	12,818
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,238	11,088	11,493
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,523	7,044	6,974
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	15,287	12,224	9,041
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.16	19.16	19.16
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,982,520	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	12.14x	2.7x	7.81x	3.64%	103B
ELI LILLY AND COMPANY	34.38x	12.29x	25.6x	0.58%	1,031B
JOHNSON & JOHNSON	26.33x	6.06x	16.38x	2.17%	595B
ABBVIE INC.	30.03x	7.25x	14.87x	2.81%	431B
ROCHE HOLDING AG	17.64x	4.37x	10.78x	3.03%	326B
NOVARTIS AG	21.13x	5.43x	13.15x	2.91%	277B
ASTRAZENECA PLC	21.17x	4.46x	12.34x	1.97%	263B
NOVO NORDISK A/S	14.47x	5.42x	11.17x	3.43%	224B
AMGEN INC.	23.5x	6.23x	11.02x	2.81%	193B
GILEAD SCIENCES, INC.	-47.44x	5.68x	31.37x	2.46%	164B
Average	15.33x	5.99x	15.45x	2.58%	360.72B
Weighted average by Cap.	22.87x	7.52x	17.61x	2.08%